Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antimicrobial mouthwashes and SARS-CoV-2 detection in adults with COVID-19 in Ghana
PACTR202108837577420Phase 3Not yet recruiting
- Sponsor
- National Research Foundation South Africa
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of chlorhexidine, povidone-iodine and hydrogen peroxide in coronavirus disease 2019 (COVID-19) (4 arms), sponsored by National Research Foundation South Africa. Primary endpoint: Reduction in viral load of SARS-CoV-2. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
chlorhexidinepovidone-iodinehydrogen peroxide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202108837577420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202108837577420.